The mechanism in most patients is inadequate production of red blood cells due to either erythropoietin deficiency from accompanying renal failure or pronounced marrow replacement by myeloma cells [10–12]. This evidence concerns the gene EPO and hyperinsulinemic hypoglycemia, familial, 4.